drugset / Trial / NCT01483833

Efficacy Study of Iferanserin to Treat Hemorrhoids

NCT01483833 ↗

Phase 2 Completed 121 enrolled Ventrus Biosciences, Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the safety and efficacy of topical 0.5% S-MPEC cream vs. placebo cream (applied twice daily for 14 days) in the treatment of Grade I - III hemorrhoids.

Timeline

Start
2001-09
Primary completion
2002-08
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iferanserin Small molecule 10 mg Other

Indications